Targeting YTHDF1 effectively re-sensitizes cisplatin-resistant colon cancer cells by modulating GLS-mediated glutamine metabolism
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine
Reference25 articles.
1. Colorectal cancer;Dekker;Lancet,2019
2. Personalizing colon cancer adjuvant therapy: selecting optimal treatments for individual patients;Dienstmann;J. Clin. Oncol.,2015
3. Adjuvant chemotherapy for stage II and III colon cancer following complete resection: a Cancer Care Ontario systematic review;Meyers;Clin. Oncol. (R. Coll. Radiol.),2017
4. Cisplatin in cancer therapy: molecular mechanisms of action;Dasari;Eur. J. Pharmacol.,2014
5. Molecular mechanisms of cisplatin resistance;Galluzzi;Oncogene,2012
Cited by 90 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Hemostatic nanofibers/chitosan composite aerogel for potential chemo-photothermal therapy;Journal of Molecular Structure;2025-01
2. Unraveling the role of long non-coding RNAs in therapeutic resistance in acute myeloid leukemia: New prospects & challenges;Non-coding RNA Research;2024-12
3. Glutamine metabolism promotes human trophoblast cell invasion via COL1A1 mediated by PI3K-AKT pathway;Journal of Reproductive Immunology;2024-12
4. The interaction between m6A modification and noncoding RNA in tumor microenvironment on cancer progression;International Immunopharmacology;2024-10
5. YTHDF1 facilitates esophageal cancer progression via augmenting m6A-dependent TINAGL1 translation;Cellular Signalling;2024-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3